Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial

Published:October 22, 2014DOI:https://doi.org/10.1016/j.dld.2014.09.004

      Abstract

      Background

      Probiotics may help resolve bowel symptoms and improve quality of life. We investigated the effects of 12 weeks of probiotics administration in colorectal cancer patients.

      Methods

      We conducted a double-blind, randomized, placebo-controlled trial. The participants took probiotics ( Lacidofil) or placebo twice a day for 12 weeks. The cancer-related quality of life (FACT), patient's health-9 (PHQ-9), and bowel symptom questionnaires were completed by each participant.

      Results

      We obtained data for 32 participants in the placebo group and 28 participants in the probiotics group. The mean ages of total participants were 56.18 ± 8.86 years and 58.3% were male. Administration of probiotics significantly decreased the proportion of patients suffering from irritable bowel symptoms (0 week vs. 12 week; 67.9% vs. 45.7%, p = 0.03), improved colorectal cancer-related FACT (baseline vs. 12 weeks: 19.79 ± 4.66 vs. 21.18 ± 3.67, p = 0.04) and fatigue-related FACT (baseline vs. 12 weeks: 43.00 (36.50–45.50) vs. 44.50 (38.50–49.00), p = 0.02) and PHQ-9 scores (0 weeks vs. 12 weeks; 3.00 (0–8.00) vs. 1.00 (0–3.00), p = 0.01). We found significant differences in changes of the proportion of patients with bowel symptoms ( p < 0.05), functional well-being scores ( p = 0.04) and cancer-related FACT scores ( p = 0.04) between the two groups.

      Conclusion

      Probiotics improved bowel symptoms and quality of life in colorectal cancer survivors.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Lertkhachonsuk A.-A.
        • Yip C.H.
        • Khuhaprema T.
        • et al.
        Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.
        Lancet Oncology. 2013; 14: e497-e507
        • Jemal A.
        • Siegel R.
        • Ward E.
        • et al.
        Cancer statistics, 2008.
        CA: A Cancer Journal for Clinicians. 2008; 58: 71-96
        • Phipps E.
        • Braitman L.E.
        • Stites S.
        • et al.
        Quality of life and symptom attribution in long-term colon cancer survivors.
        Journal of Evaluation in Clinical Practice. 2008; 14: 254-258
        • Vironen J.H.
        • Matti Kairaluoma M.
        • Aalto A.-M.
        • et al.
        Impact of functional results on quality of life after rectal cancer surgery.
        Diseases of the Colon and Rectum. 2006; 49: 568-578
        • Camilleri-Brennan J.
        • Steele R.
        Quality of life after treatment for rectal cancer.
        British Journal of Surgery. 1998; 85: 1036-1043
        • Scheer A.S.
        • Boushey R.P.
        • Liang S.
        • et al.
        The long-term gastrointestinal functional outcomes following curative anterior resection in adults with rectal cancer: a systematic review and meta-analysis.
        Diseases of the Colon and Rectum. 2011; 54: 1589-1597
        • Ho Y.H.
        • Low D.
        • Goh H.-S.
        Bowel function survey after segmental colorectal resections.
        Diseases of the Colon and Rectum. 1996; 39: 307-310
        • Bregendahl S.
        • Emmertsen K.J.
        • Lous J.
        • et al.
        Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study.
        Colorectal Disease. 2013; 15: 1130-1139
        • Yang L.
        • Pei Z.
        Bacteria, inflammation, and colon cancer.
        World Journal of Gastroenterology. 2006; 12: 6741
        • Guandalini S.
        Probiotics for children with diarrhea: an update.
        Journal of Clinical Gastroenterology. 2008; 42: S53-S57
        • Saavedra J.M.
        • Bauman N.
        • Perman J.
        • et al.
        Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus.
        The Lancet. 1994; 344: 1046-1049
        • Bai A.
        • Ouyang Q.
        Probiotics and inflammatory bowel diseases.
        Postgraduate Medical Journal. 2006; 82: 376-382
        • Brenner D.M.
        • Moeller M.J.
        • Chey W.D.
        • et al.
        The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.
        American Journal of Gastroenterology. 2009; 104: 1033-1049
        • McFarland L.V.
        • Dublin S.
        Meta-analysis of probiotics for the treatment of irritable bowel syndrome.
        World Journal of Gastroenterology. 2008; 14: 2650
        • Saggioro A.
        Probiotics in the treatment of irritable bowel syndrome.
        Journal of Clinical Gastroenterology. 2004; 38: S104-S106
        • Yoon J.S.
        • Sohn W.
        • Lee O.Y.
        • et al.
        Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
        Journal of Gastroenterology and Hepatology. 2014; 29: 52-59
        • Bengmark S.
        Ecological control of the gastrointestinal tract. The role of probiotic flora.
        Gut. 1998; 42: 2-7
        • Menard S.
        • Candalh C.
        • Bambou J.
        • et al.
        Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport.
        Gut. 2004; 53: 821-828
        • Pathmakanthan S.
        • Li C.K.
        • Cowie J.
        • et al.
        Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon.
        Journal of Gastroenterology and Hepatology. 2004; 19: 166-173
        • Ohigashi S.
        • Hoshino Y.
        • Ohde S.
        • et al.
        Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer.
        Surgery Today. 2011; 41: 1200-1206
        • Longstreth G.F.
        • Thompson W.G.
        • Chey W.D.
        • et al.
        Functional bowel disorders.
        Gastroenterology. 2006; 130: 1480-1491
        • Cella D.F.
        • Tulsky D.S.
        • Gray G.
        • et al.
        The functional assessment of cancer therapy scale: development and validation of the general measure.
        Journal of Clinical Oncology. 1993; 11: 570-579
        • Kroenke K.
        • Spitzer R.L.
        The PHQ-9: a new depression diagnostic and severity measure.
        Psychiatric Annals. 2002; 32: 1-7
        • Sekine K.
        • Toida T.
        • Saito M.
        • et al.
        A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice.
        Cancer Research. 1985; 45: 1300-1307
        • Matsuzaki T.
        Immunomodulation by treatment with Lactobacillus casei strain Shirota.
        International Journal of Food Microbiology. 1998; 41: 133-140
        • Lee J.W.
        • Kim E.H.
        • Yim I.B.
        • et al.
        Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum.
        Journal of Veterinary Science. 2004; 5: 41-48
        • Morotomi M.
        • Mutal M.
        In vitro binding of potent mutagenic pyrolyzates to intestinal bacteria.
        Journal of the National Cancer Institute. 1986; 77: 195-201
        • Liu Z.
        • Qin H.
        • Yang Z.
        • et al.
        Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery – a double-blind study.
        Alimentary Pharmacology and Therapeutics. 2011; 33: 50-63
        • Bittorf B.
        • Stadelmaier U.
        • Göhl J.
        • et al.
        Functional outcome after intersphincteric resection of the rectum with coloanal anastomosis in low rectal cancer.
        European Journal of Surgical Oncology. 2004; 30: 260-265
        • Weeks J.C.
        • Nelson H.
        • Gelber S.
        • et al.
        Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer.
        Journal of the American Medical Association. 2002; 287: 321-328
        • Lee E.-H.
        • Chun M.
        • Kang S.
        • et al.
        Validation of the Functional Assessment of Cancer Therapy-General (FACT-G) scale for measuring the health-related quality of life in Korean women with breast cancer.
        Japanese Journal of Clinical Oncology. 2004; 34: 393-399
        • Yoo H.J.
        • Kim J.C.
        • Eremenco S.
        • et al.
        Quality of life in colorectal cancer patients with colectomy and the validation of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Version 4.
        Journal of Pain and Symptom Management. 2005; 30: 24-32
        • Moore W.
        • Moore L.H.
        Intestinal floras of populations that have a high risk of colon cancer.
        Applied and Environment Microbiology. 1995; 61: 3202-3207
        • Horie H.
        • Kanazawa K.
        • Kobayashi E.
        • et al.
        Effects of intestinal bacteria on the development of colonic neoplasm II. Changes in the immunological environment.
        European Journal of Cancer Prevention. 1999; 8: 533-538
        • Goulet O.
        • Joly F.
        Intestinal microbiota in short bowel syndrome.
        Gastroentérologie clinique et biologique. 2010; 34: S37-S43
        • Wardill H.R.
        • Bowen J.M.
        • Gibson R.J.
        Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal.
        Cancer Chemotherapy and Pharmacology. 2012; 70: 627-635
        • Wardill H.R.
        • Bowen J.M.
        Chemotherapy-induced mucosal barrier dysfunction: an updated review on the role of intestinal tight junctions.
        Current Opinion in Supportive and Palliative Care. 2013; 7: 155-161
        • Guarner F.
        • Malagelada J-R.
        Gut flora in health and disease.
        Lancet. 2003; 361: 512-519
        • Grimoud J.
        • Durand H.
        • De Souza S.
        • et al.
        In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects.
        International Journal of Food Microbiology. 2010; 144: 42-50
        • De Giorgio R.
        • Barbara G.
        Is irritable bowel syndrome an inflammatory disorder.
        Current Gastroenterology Reports. 2008; 10: 385-390
        • Műzes G.
        • Molnár B.
        • Tulassay Z.
        • et al.
        Changes of the cytokine profile in inflammatory bowel diseases.
        World Journal of Gastroenterology. 2012; 18: 5848
        • Barbara G.
        • Cremon C.
        • Carini G.
        • et al.
        The immune system in irritable bowel syndrome.
        Journal of Neurogastroenterology and Motility. 2011; 17: 349-359
        • Spiller R.
        • Garsed K.
        Postinfectious irritable bowel syndrome.
        Gastroenterology. 2009; 136: 1979-1988
        • Mayer E.A.
        Gut feelings: the emerging biology of gut–brain communication.
        Nature Reviews Neuroscience. 2011; 12: 453-466
        • Bercik P.
        • Collins S.
        • Verdu E.
        Microbes and the gut–brain axis.
        Neurogastroenterology and Motility. 2012; 24: 405-413
        • Benton D.
        • Williams C.
        • Brown A.
        Impact of consuming a milk drink containing a probiotic on mood and cognition.
        European Journal of Clinical Nutrition. 2006; 61: 355-361
        • Rao A.V.
        • Bested A.C.
        • Beaulne T.M.
        • et al.
        A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome.
        Gut Pathogens. 2009; 1: 1-6
        • Singh P.
        • Chopra K.
        • Kuhad A.
        • et al.
        Role of Lactobacillus acidophilus loaded floating beads in chronic fatigue syndrome: behavioral and biochemical evidences.
        Neurogastroenterology and Motility. 2012; 24: 366-e170
        • Wagner L.
        • Cella D.
        Fatigue and cancer: causes, prevalence and treatment approaches.
        British Journal of Cancer. 2004; 91: 822-828
        • Mitchell A.J.
        • Ferguson D.W.
        • Gill J.
        • et al.
        Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis.
        Lancet Oncology. 2013; 14: 721-732
        • Gianotti L.
        • Morelli L.
        • Galbiati F.
        • et al.
        A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients.
        World Journal of Gastroenterology. 2010; 16: 167